15:39 21/11/2014 Why Pfizer Inc. (PFE) May Not Bid For AstraZeneca plc (ADR) (AZN) Again?
Why Pfizer Inc. (PFE) May Not Bid For AstraZeneca plc (ADR) (AZN) Again?
InvestCorrectly - Nov 21, 2014
If investors thought Pfizer Inc. (NYSE:PFE) would still pursue AstraZeneca plc (ADR) (NYSE:AZN) deal then their hopes are up in the air.
Merck Collaboration Rules Out AstraZeneca Acquisition--For Now - Seeking Alpha
Healthcare Stocks in the Spotlight - Pfizer Inc. (NYSE:PFE), DaVita HealthCare ... - Techsonian (press release)

14:05 18/11/2014 Sanguine's Mobile Application to Assist Recruitment for Pfizer Inc. Chronic ...
Sanguine's Mobile Application to Assist Recruitment for Pfizer Inc. Chronic ...
MarketWatch - Nov 18, 2014
LOS ANGELES, Nov. 18, 2014 /PRNewswire/ -- Sanguine Biosciences - a biotechnology company focusing on technology development, patient engagement and study recruitment - will use its proprietary mobile application and direct-to-patient platform, ...

9:18 17/11/2014 Pfizer, Germany's strike deal to develop cancer tumor treatment
Pfizer, Germany's strike deal to develop cancer tumor treatment
MarketWatch - Nov 17, 2014
FRANKFURT - Pfizer Inc. and Germany's Merck KGaA are teaming up to develop a new tumor treatment product, in a move that will boost the U.S.
Pfizer Cancer Pact With Merck Shows Waning Astra Pursuit - Bloomberg
Merck KGaA, Darmstadt, Germany, Announces Global Strategic Alliance with ... - Stockhouse

15:20 16/11/2014 AbbVie Inc. vs. Pfizer Inc.: Which Is the Better Dividend Stock?
AbbVie Inc. vs. Pfizer Inc.: Which Is the Better Dividend Stock?
Motley Fool - Nov 16, 2014
Dividend stocks are powerful long-term investing vehicles that should be an integral part of a well balanced portfolio. Picking good dividend stocks, though, is another story altogether.

12:56 12/11/2014 Warren Buffett's Investing Strategy: Is Pfizer Inc. a Perfect Fit?
Warren Buffett's Investing Strategy: Is Pfizer Inc. a Perfect Fit?
Motley Fool - Nov 12, 2014
Yet, one company you won't currently find in Buffett and Berkshire's portfolio is the world's largest pharmaceutical company by revenue, Pfizer (NYSE: PFE ) . Today, we'll take a closer look at whether or not Pfizer would make a perfect fit for Warren ...

15:11 01/11/2014 3 Dividend Stocks Better Than Pfizer, Inc.
3 Dividend Stocks Better Than Pfizer, Inc.
Motley Fool - Nov 1, 2014
Pfizer (NYSE: PFE ) reported third-quarter earnings this week that were generally underwhelming. The drugmaker announced that its sales sagged 2.2% to $12.36 billion and its adjusted EPS fell similarly by 2% year over year in the quarter.

20:46 31/10/2014 Op-Ed: Pfizer Inc. is active, vital, taxpaying part of Eastern Connecticut
Op-Ed: Pfizer Inc. is active, vital, taxpaying part of Eastern Connecticut
The CT Mirror - Oct 31, 2014
The Chamber of Commerce of Eastern Connecticut would like to set the record straight regarding Pfizer Inc.'s presence and future in southeastern Connecticut.

13:56 20/10/2014 Can This 1 Breast Cancer Drug Turn Pfizer Inc. Into a Growth Stock?
Can This 1 Breast Cancer Drug Turn Pfizer Inc. Into a Growth Stock?
Motley Fool - Oct 20, 2014
Big Pharma is undergoing a radical face-lift due to the avalanche of top-selling drugs losing patent protection. The consequences of the aptly named "patent cliff" have been widespread and immense in scope.

13:27 25/09/2014 Should Pfizer Inc. Buy Actavis plc?
Should Pfizer Inc. Buy Actavis plc?
Motley Fool - Sep 25, 2014
Earlier this year, a media circus erupted over Pfizer's reported interest in AstraZeneca (NYSE: AZN ) . The deal would have exceeded $100 billion and created a company roughly the same size as Johnson & Johnson. AstraZeneca brass, however, felt the ...
Pfizer Inc. Is Kicking The Tires At Actavis PLC - Benzinga
Pfizer Inc. May Be Interested In Buying Actavis plc [REPORT] - ValueWalk

14:41 11/09/2014 Why I'd Avoid Pfizer Inc. Stock Despite the Dividend
Why I'd Avoid Pfizer Inc. Stock Despite the Dividend
Motley Fool - Sep 11, 2014
Pfizer's problem in the clinic is uncertainty regarding its ability to generate new blockbuster drugs. The company decided, along with almost every other Big Pharma simultaneously, to go after novel oncology and high cholesterol drugs to replace former ...